Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Benvenue Medical Inc. Stories

2014-03-24 08:29:46

KAST Pivotal Trial Results Plus other Published Comparative Studies Show Kiva Meets or Exceeds Balloon Kyphoplasty Performance SAN DIEGO, Calif., March 24, 2014 /PRNewswire/ -- Benvenue Medical, Inc. announced the full commercial launch of the Kiva VCF Treatment System for the reduction and treatment of spine fractures at the Society for Interventional Radiology Annual Scientific Meeting, where results from KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and...

2014-02-25 08:32:19

Spine Study Shows Kiva Reduced Pain without Extravasation SANTA CLARA, Calif., Feb. 25, 2014 /PRNewswire/ -- Benvenue Medical, Inc., today announced results of an independent, prospective, randomized study which found that the company's Kiva(® )VCF Treatment System was as effective as balloon kyphoplasty (BKP) in reducing pain associated with osteolytic vertebral body metastases. The Kiva System also resulted in no extravasation (cement leakage) while BKP, the current standard of care,...

2014-02-19 08:32:42

WASHINGTON and SANTA CLARA, Calif., Feb. 19, 2014 /PRNewswire/ -- The George Washington University Hospital and Benvenue Medical, Inc., announced that it is the first in the U.S. to treat vertebral compressions fracture (VCF) patients with the Kiva VCF Treatment System following its clearance by the U.S. Food and Drug Administration in January. The minimally invasive Kiva System, which demonstrated important patient benefits in a large, international, FDA-approved clinical trial, is...

2014-01-28 08:29:38

First New Vertebral Augmentation Treatment Approach in Over a Decade SANTA CLARA, Calif., Jan. 28, 2014 /PRNewswire/ -- The Kiva(®) VCF Treatment System by Benvenue Medical, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the reduction and treatment of spinal fractures. The Kiva System is a novel implant-based solution for vertebral augmentation and a departure from balloon kyphoplasty (BKP), making it the first new approach to the treatment of...

2013-10-29 08:33:23

Pain Physician Journal Publishes Results that Show Significantly Better Pain Improvement and Fewer New Fractures with Kiva SANTA CLARA, Calif., Oct. 29, 2013 /PRNewswire/ -- An independent evaluation of the safety and effectiveness of the Kiva VCF Treatment System, developed by Benvenue Medical, Inc., compared with balloon kyphoplasty, found that Kiva delivered significant improvements in back pain. The Kiva system also resulted in significantly fewer new fractures and half the mean cement...

2013-10-09 08:27:15

Award from Orthopedics This Week Honors Best Spine Products, Engineers and Inventors SANTA CLARA, Calif., Oct. 9, 2013 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, won the 2013 Spine Technology Award in the minimally invasive spine care category for its Kiva VCF Treatment System. The fifth annual Spine Technology Awards are being presented by Orthopedics This Week and RRY Publications LLC at the North American Spine Society...

2013-09-10 08:30:04

Highlights Clinical Studies Supporting Clinical Effectiveness of Kiva® VCF Treatment System and Superiority Over Balloon-Assisted Vertebral Augmentation in Key Areas SANTA CLARA, Calif., Sept. 10, 2013 /PRNewswire/ -- Benvenue Medical, Inc., will host a satellite symposium at the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) in Barcelona, Spain on Monday, September 16. The session, "Clinical Evidence in the Treatment of Vertebral Compression...

2013-05-21 08:29:16

SANTA CLARA, Calif., May 21, 2013 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it has completed the 12-month patient follow-up phase in the KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. KAST is being conducted to support a 510(k) application for market clearance from the U.S. Food and Drug Administration (FDA), which Benvenue Medical expects to submit in the...

2013-04-22 08:29:19

Published in Techniques in Regional Anesthesia and Pain Management, Review Article Discusses Emerging VCF Treatments and Technologies SANTA CLARA, Calif., April 22, 2013 /PRNewswire/ -- In a review of minimally invasive, state-of-the-art treatments for vertebral compression fractures (VCFs), the Kiva VCF Treatment System and the Blazer Vertebral Augmentation System, both by Benvenue Medical, Inc., were highlighted among the most innovative experimental and commercial technologies...

2013-03-18 08:29:56

Published in Pain Physician Journal, Study Also Concludes Implant Design May Reduce Extravasation vs. Vertebroplasty and Kyphoplasty SANTA CLARA, Calif., March 18, 2013 /PRNewswire/ -- A physician-driven prospective study of patients with painful osteolytic vertebral metastases treated with the Kiva VCF Treatment System by Benvenue Medical, Inc. found all patients experienced a clinically relevant improvement in pain and statistically significant functional improvement. The...